DrugCite
Search

CALCIUM FOLINATE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Calcium Folinate Adverse Events Reported to the FDA Over Time

How are Calcium Folinate adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Calcium Folinate, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Calcium Folinate is flagged as the suspect drug causing the adverse event.

Most Common Calcium Folinate Adverse Events Reported to the FDA

What are the most common Calcium Folinate adverse events reported to the FDA?

Diarrhoea
43 (3.07%)
Vomiting
35 (2.5%)
Nausea
29 (2.07%)
Death
28 (2%)
Pyrexia
28 (2%)
Intestinal Obstruction
21 (1.5%)
Sepsis
21 (1.5%)
Neutropenia
20 (1.43%)
Dehydration
19 (1.36%)
Pulmonary Embolism
19 (1.36%)
Abdominal Pain
17 (1.22%)
Show More Show More
Anaemia
17 (1.22%)
Thrombocytopenia
17 (1.22%)
Ascites
15 (1.07%)
Renal Failure Acute
14 (1%)
Dyspnoea
13 (.93%)
Leukopenia
13 (.93%)
Pneumonia
13 (.93%)
Febrile Neutropenia
12 (.86%)
General Physical Health Deteriorati...
12 (.86%)
Haematuria
11 (.79%)
Asthenia
10 (.71%)
Disease Progression
10 (.71%)
Jugular Vein Thrombosis
10 (.71%)
Renal Impairment
10 (.71%)
Respiratory Failure
10 (.71%)
Anal Abscess
9 (.64%)
Anorexia
9 (.64%)
Chills
9 (.64%)
Constipation
9 (.64%)
Mucosal Inflammation
9 (.64%)
Pancytopenia
9 (.64%)
Acute Myocardial Infarction
8 (.57%)
Atrial Fibrillation
8 (.57%)
Blood Creatinine Increased
8 (.57%)
Chest Pain
8 (.57%)
Gastrointestinal Haemorrhage
8 (.57%)
Hypotension
8 (.57%)
Ileus
8 (.57%)
Neutropenic Sepsis
8 (.57%)
Stress Cardiomyopathy
8 (.57%)
White Blood Cell Count Decreased
8 (.57%)
Blood Bilirubin Increased
7 (.5%)
Cardiac Arrest
7 (.5%)
Hypertension
7 (.5%)
Hypovolaemia
7 (.5%)
Jaundice
7 (.5%)
Small Intestinal Obstruction
7 (.5%)
Subcutaneous Abscess
7 (.5%)
Alanine Aminotransferase Increased
6 (.43%)
Aspartate Aminotransferase Increase...
6 (.43%)
Colorectal Cancer
6 (.43%)
Confusional State
6 (.43%)
Cutaneous Vasculitis
6 (.43%)
Depressed Level Of Consciousness
6 (.43%)
Haemolytic Uraemic Syndrome
6 (.43%)
Hydronephrosis
6 (.43%)
Ileitis
6 (.43%)
Infection
6 (.43%)
Multi-organ Failure
6 (.43%)
Myocardial Infarction
6 (.43%)
Nephrotic Syndrome
6 (.43%)
Renal Vasculitis
6 (.43%)
Tachycardia
6 (.43%)
Wound Decomposition
6 (.43%)
Bacteraemia
5 (.36%)
Blood Alkaline Phosphatase Increase...
5 (.36%)
Cerebral Infarction
5 (.36%)
Colonic Obstruction
5 (.36%)
Disseminated Intravascular Coagulat...
5 (.36%)
Dizziness
5 (.36%)
Electrocardiogram St Segment Depres...
5 (.36%)
Generalised Oedema
5 (.36%)
Hepatic Failure
5 (.36%)
Hepatic Function Abnormal
5 (.36%)
Hyponatraemia
5 (.36%)
Neuropathy Peripheral
5 (.36%)
Palmar-plantar Erythrodysaesthesia ...
5 (.36%)
Vascular Purpura
5 (.36%)
Amnesia
4 (.29%)
Arrhythmia
4 (.29%)
Cardiac Tamponade
4 (.29%)
Cerebral Ischaemia
4 (.29%)
Encephalopathy
4 (.29%)
Epistaxis
4 (.29%)
Erythrosis
4 (.29%)
Fatigue
4 (.29%)
Gastrointestinal Necrosis
4 (.29%)
Haemoptysis
4 (.29%)
Malignant Neoplasm Progression
4 (.29%)
Muscular Weakness
4 (.29%)
Paraesthesia
4 (.29%)
Pericardial Effusion
4 (.29%)
Pleuritic Pain
4 (.29%)
Proteinuria
4 (.29%)
Renal Failure
4 (.29%)
Right Ventricular Failure
4 (.29%)
Septic Shock
4 (.29%)
Status Epilepticus
4 (.29%)
Stomatitis
4 (.29%)
Ventricular Tachycardia
4 (.29%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Calcium Folinate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Calcium Folinate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Calcium Folinate

What are the most common Calcium Folinate adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Calcium Folinate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Calcium Folinate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Calcium Folinate According to Those Reporting Adverse Events

Why are people taking Calcium Folinate, according to those reporting adverse events to the FDA?

Colorectal Cancer
164
Colorectal Cancer Metastatic
90
Colon Cancer
63
Drug Use For Unknown Indication
54
Rectal Cancer
34
Prophylaxis
24
Show More Show More
Rheumatoid Arthritis
11
Cerebral Toxoplasmosis
10
Colon Cancer Metastatic
10
Vitamin Supplementation
9
Gastric Cancer
8
Metastatic Gastric Cancer
7
Metastasis
7
Product Used For Unknown Indication
7
Adverse Drug Reaction
6
Breast Cancer Metastatic
5
Chemotherapy
5
Breast Cancer
5
Adenocarcinoma
5
Medical Diet
5
Oesophageal Carcinoma
4
Colon Cancer Stage Iii
4
Metastases To Liver
4
Anaemia Prophylaxis
4
Large Intestine Carcinoma
4
Acute Lymphocytic Leukaemia
4
Premedication
3
Toxoplasmosis
3
Haematotoxicity
2
Rectal Cancer Stage Iii
2
Infection Prophylaxis
2
Arthritis
2
Biliary Neoplasm
2
Mantle Cell Lymphoma
2
Supplementation Therapy
2
Breast Cancer Female
2
Hepatic Neoplasm Malignant
2
Metastases To Lung
2
Colorectal Cancer Stage Iii
2
Eye Infection Toxoplasmal
2
Pancreatic Carcinoma
1
Oesophageal Adenocarcinoma
1
Psoriatic Arthropathy
1
Rectal Cancer Metastatic
1
Prostate Cancer
1
Prophylaxis Against Graft Versus Ho...
1
Hodgkins Disease
1
Ill-defined Disorder
1
Mineral Supplementation
1
Colon Cancer Stage Ii
1
Metastases To Ovary
1

Drug Labels

LabelLabelerEffective
Calcium FolinateTeva Parenteral Medicines, Inc24-JUL-12

Calcium Folinate Case Reports

What Calcium Folinate safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Calcium Folinate. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Calcium Folinate.